Close Menu
    Business

    UBS sells Concord Biotech, IIFL Securities, 2 more stocks worth Rs 480 crore in block trade

    ElcioBy No Comments3 Mins Read0 Views

    UBS The Zurich-based banking and monetary companies firm went on a promoting spree on Friday when it offered 4 of its holdings by way of UBS Main Capital Asia Restricted. block trade. The shares embody Xiehe Biotechnology, Five Star Corporate Finance, IIFL Securities and marxans pharmaceuticals Whole share gross sales amounted to Rs 480 crore.

    UBS offered 740,159 million shares price Rs 1.92 billion at Rs 2,589.86 per share, a 15 per cent premium to Thursday’s closing worth of Rs 2,250.55. The inventory closed at Rs 2,591 at this time, up Rs 340.45 or 15.13%.

    In 5 Star Enterprise Finance, UBS offered 15,80,163 shares at Rs 804.74 per share. Whole gross sales amounted to Rs 127 crore. The inventory was offered at a premium of 4.4% to the earlier closing worth of Rs 770.75. The inventory closed at Rs 811 at this time, up Rs 40.25, or 5.22%.

    UBS Main offered 17,10,992 shares of IIFL Securities price Rs 53 crore. The value was 309.84 rupees per share, a 2% low cost to Thursday’s closing worth of 316.45 rupees. The inventory closed at Rs 330 on the NSE, up Rs 13.55, or 4.28 per cent.

    In Marksans Pharma, UBS offered 34,01,630 shares for Rs 108 crore. The shares had been offered at Rs 317.22, a premium of 16% to Thursday’s closing worth of Rs 274.44. The inventory closed at Rs 327.97 on the NSE, up Rs 53.53, or 19.51%. Marksans additionally touched a recent 52-week excessive of Rs 328.80.

    rapid growth


    Additionally learn: Sebi relaxes financial curbs on technical glitches, restricting them to market infrastructure institutions(Disclaimer: The recommendation, solutions, views and opinions given by consultants are private and don’t symbolize the views of The Financial Instances)

    Source link

    Share.

    Related Posts

    Comments are closed.